Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/15/2014US20140134187 Therapeutic and diagnostic methods for autism spectrum disorders and other conditions
05/15/2014US20140134185 Composition Comprising Inhibitors of IRS-1 and of VEGF
05/15/2014US20140134182 Antibodies of the ed-b domain of fibronectin, their construction and uses
05/15/2014US20140134170 Use of inhibitors of egfr-family receptors in the treatment of hormone refractory breast cancers
05/15/2014US20140134169 Methods of Treating Ovarian Cancer with Dll4 Antagonists
05/15/2014US20140134167 Transforming growth factor-beta (TGF-beta) antagonists for use in treating pain
05/15/2014US20140134163 Combination therapy with mdm2 and efgr inhibitors
05/15/2014US20140134161 Egfr targeted therapy
05/15/2014US20140134160 Gemcitabine prodrugs and uses thereof
05/15/2014US20140134157 Antibodies to opgl
05/15/2014US20140134138 Novel Use of Cryptotanshinone
05/15/2014US20140134135 Methods and compositions for preserving lean body mass during weight loss
05/15/2014US20140134134 Use of a combination of myxoma virus and rapamycin for therapeutic treatment
05/15/2014US20140134133 Heteroaromatic compounds as pi3 kinase modulators and methods of use
05/15/2014US20140134130 Fused bicyclic oxalamide compounds for the treatment of hepatitis c
05/15/2014US20140134119 Rosacea treatments using polymetal complexes
05/15/2014US20140134113 Pharmaceutical compositions
05/15/2014US20140134111 Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases
05/15/2014DE102013107024A1 Methoden und Zusammensetzungen zum Behandeln, Modifizieren und Handhaben von Knochenkrebsschmerz Methods and compositions for treating, modifying and manipulating bone cancer pain
05/14/2014EP2730604A2 Functionalized caprolactone monomers useful for making poly(ethylene oxide)-block-poly(ester) block copolymers
05/14/2014EP2730577A1 Crystal modification of a para-methoxyanilide of 6-hydroxy-4-oxo-2,4,dihydro-1h-pyrrolo[3,2,1-ij]-quinoline-5-carboxylic acid
05/14/2014EP2730576A2 Anti-infective compounds
05/14/2014EP2730575A1 Crystal form i of salt of dipeptidyl peptidase-iv inhibitor and preparation method and use thereof
05/14/2014EP2730573A1 Methylpiperidine derivative
05/14/2014EP2730572A1 Spiro compounds as hepatitis c virus inhibitors
05/14/2014EP2730571A1 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives
05/14/2014EP2730565A1 Tumor targeted drug combretastatin a4 derivative
05/14/2014EP2730564A1 Heterocycle amines and uses thereof
05/14/2014EP2730559A1 Deuterated phenylpropionic acid derivative
05/14/2014EP2730558A1 Indole derivatives, pharmaceutical compositions containing such indoles and their use as DNA methylation modulators
05/14/2014EP2730290A1 Adhesive skin patch containing serotonin receptor antagonist drug
05/14/2014EP2730286A2 Composition for maintaining bone health and for treating osteoarthritis and osteoarthrosis of the joints
05/14/2014EP2730285A1 Use of NAD and beta NAD as bronchodilatators
05/14/2014EP2730284A1 Levonorgestrel-only-composition for optimized oral contraception with defined levonorgestrel content, dosage regimen and pharmaceutical preparation
05/14/2014EP2730283A1 Pharmaceutical composition for inflammatory diseases, allergic diseases and autoimmune diseases
05/14/2014EP2730282A1 Methods and compositions for the treatment of proteinuric diseases
05/14/2014EP2730281A1 Anti-obesity agent comprising high-purity epa
05/14/2014EP2730280A1 A pharmaceutical composition comprising a menthane carboxylic acid amide
05/14/2014EP2730278A1 Composition melt
05/14/2014EP2730277A2 Drug carrier and drug carrier kit for inhibiting fibrosis
05/14/2014EP2730271A1 Aqeuous compositions
05/14/2014EP2730168A1 Powder composition for disinfection of the teats of dairy animals
05/14/2014EP2729605A1 Rna-yy1 interactions
05/14/2014EP2729476A1 Heteroaryl-substituted pyrazolopyridines and use thereof as soluble guanylate cyclase stimulators
05/14/2014EP2729475A1 Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring
05/14/2014EP2729474A1 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
05/14/2014EP2729473A1 Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring
05/14/2014EP2729472A1 Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring
05/14/2014EP2729471A1 Carboxylic acid derivatives having an oxazolo[5,4-d]pyridine ring
05/14/2014EP2729470A1 Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
05/14/2014EP2729469A1 Orvinol and thevinol derivatives useful in the treatment of drug and alcohol abuse
05/14/2014EP2729468A2 Tricyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors
05/14/2014EP2729466A1 Novel pyrrolo pyrimidine derivatives
05/14/2014EP2729461A1 Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride
05/14/2014EP2729460A1 Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride
05/14/2014EP2729459A1 Substituted azaheterocycles for the treatment of cancer
05/14/2014EP2729455A1 Biaryl derivatives as nachr modulators
05/14/2014EP2729454A1 Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
05/14/2014EP2729453A1 Pyrimidinone compounds and their use
05/14/2014EP2729450A1 N- (2 -aminophenyl) benzamide derivatives as histone deacetylase inhibitors
05/14/2014EP2729449A1 5- or 6 - substituted 3 - hydroxy - 2 ( 1h) - pyridinones as d-amino acid oxidase (daao) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain
05/14/2014EP2729448A1 Compounds for the treatment of hiv
05/14/2014EP2729447A1 Positive allosteric modulators of nicotinic acetylcholine receptor
05/14/2014EP2729445A1 Cyclic amine derivatives as ep4 receptor antagonists
05/14/2014EP2729217A1 Improvements in or relating to visual performance and/or macular pigmentation
05/14/2014EP2729216A1 Pharmaceutical composition for neurological disorders
05/14/2014EP2729183A1 Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors
05/14/2014EP2729179A1 Macromolecules
05/14/2014EP2729154A1 Hemostatic agent particularly for use in surgical procedures
05/14/2014EP2729153A1 Condensed pyrimidine nucleoside analogs as anti -viral agents
05/14/2014EP2729152A1 Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome
05/14/2014EP2729151A1 Pharmaceutical composition, methods for treating and uses thereof
05/14/2014EP2729150A2 Factor ixa inhibitors
05/14/2014EP2729149A1 Voltage-gated sodium channel blockers
05/14/2014EP2729148A1 Compositions and methods for treatment of symptoms in parkinson's disease patients
05/14/2014EP2729147A1 Nk-1 receptor antagonists for treating corneal neovascularisation
05/14/2014EP2729146A1 Medicament for treatment of liver cancer
05/14/2014EP2729145A2 Pyrroloquinolinyl-pyrrolidine-2,5-dione formulations and methods for preparing and using same
05/14/2014EP2729144A2 Treating cancer with hsp90 inhibitory compounds
05/14/2014EP2729143A1 Use of biotin for the treatment of multiple sclerosis
05/14/2014EP2729142A2 Method of treating atherosclerosis in high triglyceride subjects
05/14/2014EP2729141A1 Cyclic amine derivatives as ep4 receptor agonists
05/14/2014EP2729140A1 Dronedarone for the prevention of atrial fibrillation
05/14/2014EP2729139A1 Cough reducing product
05/14/2014EP2729138A1 Anticonvulsant activity of turmeric oil and bisabolene sesquiterpenoids
05/14/2014EP2729137A1 Topical compositions for use in the prevention and/or treatment of dermatitis
05/14/2014EP2729136A1 Drug combinations and uses in treating a coughing condition
05/14/2014EP2729132A1 Pharmaceutical composition and solid galenic form having a high dronedarone content, and method for preparing same
05/14/2014EP2729130A1 Darunavir combination formulations
05/14/2014EP2729128A1 Darunavir formulations
05/14/2014EP2729123A2 Cannabinoid receptor binding agents, compositions and methods
05/14/2014EP2729121A1 Chewing gum having sustained release of nicotine
05/14/2014EP2729008A1 Systems, methods, and formulations for treating cancer
05/14/2014EP2729004A1 Treatment of methylmalonic aciduria, isovaleric aciduria, and other organic acidurias with tocotrienol quinones
05/14/2014CN203591506U 具有分解痰痂及消肿抗过敏功能的人工鼻 Sputum and swelling with exploded antiallergic function artificial nose
05/14/2014CN1968685B 互动药物的筛选 Drug interaction screening
05/14/2014CN1918162B 新的稠合吡咯并咔唑类化合物 New pyrrolocarbazole fused compounds
05/14/2014CN1738607B 沙利度胺的药物组合物和剂型 Thalidomide pharmaceutical compositions and dosage forms
05/14/2014CN103797021A 寡糖混合物以及包含该混合物的食品，特别是婴儿配方产品 And a food product comprising a mixture of oligosaccharides of the mixture, in particular infant formula
05/14/2014CN103797016A 作为神经元烟碱性乙酰胆碱受体配体的1,4-二氮杂双环[3.2.2]壬烷类 As neurons 1,4-diaza nicotinic acetylcholine receptor ligand bicyclic [3.2.2] nonane class
1 ... 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 ... 7860